Warner Chilcott to limit DTC, rely more on reps

Share this article:
Warner Chilcott said it would “make much more limited use of DTC in support of our existing brands,” relying instead on reps to drive market share gains. In a Q2 results statement, the company said advertising and promotion expenses were down $12.1 million, or 54% for the quarter, compared to Q2 2007, mainly on a reduction in DTC. The firm continues to air TV ads for its Loestrin 24. 
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Researchers hit links for charity

The PMR Charities Golf Classic teed up more than $20,000 for St. Jude Children's Research Hospital.

FDA to review Neupogen biosimilar

Novartis subsidiary Sandoz announced Thursday that the FDA has agreed to review its filgrastim biosimilar which is already approved in 40 countries.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.